Erasca, Inc. (ERAS)
14.43
-1.35
(-8.56%)
USD |
NASDAQ |
Nov 13, 10:17
Erasca Free Cash Flow (Quarterly) : -27.28M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -27.28M |
| March 31, 2026 | -27.42M |
| December 31, 2025 | -21.72M |
| September 30, 2025 | -21.66M |
| June 30, 2025 | -20.56M |
| March 31, 2025 | -31.64M |
| December 31, 2024 | -24.56M |
| September 30, 2024 | -22.42M |
| June 30, 2024 | -29.20M |
| March 31, 2024 | -33.29M |
| December 31, 2023 | -24.87M |
| September 30, 2023 | -24.36M |
| June 30, 2023 | -26.20M |
| Date | Value |
|---|---|
| March 31, 2023 | -27.56M |
| December 31, 2022 | -27.24M |
| September 30, 2022 | -25.74M |
| June 30, 2022 | -31.70M |
| March 31, 2022 | -33.14M |
| December 31, 2021 | -28.31M |
| September 30, 2021 | -27.89M |
| June 30, 2021 | -18.81M |
| March 31, 2021 | -15.79M |
| December 31, 2020 | -13.12M |
| September 30, 2020 | -7.625M |
| June 30, 2020 | -6.72M |
| March 31, 2020 | -6.168M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -181.32M |
| Twist Bioscience Corp. | -8.648M |
| Immunome, Inc. | -61.24M |
| Oncolytics Biotech, Inc. | -8.066M |
| Sangamo Therapeutics, Inc. | -19.30M |